GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » NutraLife Biosciences Inc (OTCPK:NLBS) » Definitions » Cyclically Adjusted PB Ratio

NutraLife Biosciences (NutraLife Biosciences) Cyclically Adjusted PB Ratio : (As of May. 03, 2024)


View and export this data going back to 2014. Start your Free Trial

What is NutraLife Biosciences Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


NutraLife Biosciences Cyclically Adjusted PB Ratio Historical Data

The historical data trend for NutraLife Biosciences's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NutraLife Biosciences Cyclically Adjusted PB Ratio Chart

NutraLife Biosciences Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

NutraLife Biosciences Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of NutraLife Biosciences's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, NutraLife Biosciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NutraLife Biosciences's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, NutraLife Biosciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where NutraLife Biosciences's Cyclically Adjusted PB Ratio falls into.



NutraLife Biosciences Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

NutraLife Biosciences's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2022 is calculated as:

For example, NutraLife Biosciences's adjusted Book Value per Share data for the three months ended in Sep. 2022 was:

Adj_Book=Book Value per Share/CPI of Sep. 2022 (Change)*Current CPI (Sep. 2022)
=-0.013/125.2265*125.2265
=-0.013

Current CPI (Sep. 2022) = 125.2265.

NutraLife Biosciences Quarterly Data

Book Value per Share CPI Adj_Book
201212 -0.011 96.871 -0.014
201303 0.000 98.209 0.000
201306 0.000 98.518 0.000
201309 0.000 98.790 0.000
201312 -0.003 98.326 -0.004
201403 -0.002 99.695 -0.003
201406 -0.002 100.560 -0.002
201409 -0.015 100.428 -0.019
201412 -0.043 99.070 -0.054
201503 -0.060 99.621 -0.075
201506 -0.073 100.684 -0.091
201509 -0.005 100.392 -0.006
201512 -0.007 99.792 -0.009
201603 0.000 100.470 0.000
201606 -0.006 101.688 -0.007
201609 -0.005 101.861 -0.006
201612 -0.048 101.863 -0.059
201703 0.010 102.862 0.012
201706 0.009 103.349 0.011
201709 0.000 104.136 0.000
201712 0.008 104.011 0.010
201803 0.012 105.290 0.014
201806 0.014 106.317 0.016
201809 0.011 106.507 0.013
201812 0.008 105.998 0.009
201903 0.021 107.251 0.025
201906 0.020 108.070 0.023
201909 0.017 108.329 0.020
201912 0.011 108.420 0.013
202003 0.007 108.902 0.008
202006 0.005 108.767 0.006
202009 0.002 109.815 0.002
202012 0.002 109.897 0.002
202103 0.001 111.754 0.001
202106 -0.001 114.631 -0.001
202109 -0.002 115.734 -0.002
202112 -0.004 117.630 -0.004
202203 -0.007 121.301 -0.007
202206 -0.010 125.017 -0.010
202209 -0.013 125.227 -0.013

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


NutraLife Biosciences  (OTCPK:NLBS) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


NutraLife Biosciences Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of NutraLife Biosciences's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


NutraLife Biosciences (NutraLife Biosciences) Business Description

Traded in Other Exchanges
N/A
Address
6601 Lyons Road, Suite L-6, Coconut Creek, FL, USA, 33073
NutraLife BioSciences Inc is engaged in the development, manufacturing and distribution of nutritional and dietary nutritional supplement products. The company is a branded and private label developer, manufacturer and distributor of a wide range of nutraceutical, wellness, and CBD products. It's private-label ingestible and skincare products include CBD-infused oral sprays, tinctures, pet drops, pain balms, and face creams. Its CBD products are derived from the seeds and mature stalks of the Cannabis Sativa plant which includes all parts and varieties of the cannabis sativa plant also known as hemp, which contain a tetrahydrocannabinol concentration.
Executives
Edgar Ward director, 10 percent owner, officer: President and CEO 5851 HOLMBERG RD., UNIT 2511, PARKLAND FL 33067
Neil Catania 10 percent owner, officer: Vice President 5 FIREPLACE CT., EAST NORTHPORT NY 11731
Lee White 10 percent owner, other: 10% Shareholder 130 S. RD., PAGET D0 PG06

NutraLife Biosciences (NutraLife Biosciences) Headlines

From GuruFocus

NutraLife BioSciences, Inc. (NLBS) Provides Company Update

By Marketwired Marketwired 11-12-2020

NutraLife Biosciences (OTC: NLBS) Releases Q4 2022 Shareholder Update

By Value_Insider Value_Insider 11-17-2022